Eli Lilly And Co (NYSE:LLY) major shareholder Lilly Endowment Inc sold 15,500 shares of the firm’s stock in a transaction that occurred on Tuesday, December 4th. The stock was sold at an average price of $119.00, for a total transaction of $1,844,500.00. Following the sale, the insider now owns 118,015,304 shares of the company’s stock, valued at approximately $14,043,821,176. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Lilly Endowment Inc also recently made the following trade(s):

  • On Wednesday, November 28th, Lilly Endowment Inc sold 190,000 shares of Eli Lilly And Co stock. The stock was sold at an average price of $115.57, for a total transaction of $21,958,300.00.
  • On Monday, November 19th, Lilly Endowment Inc sold 195,000 shares of Eli Lilly And Co stock. The stock was sold at an average price of $115.31, for a total transaction of $22,485,450.00.
  • On Friday, November 16th, Lilly Endowment Inc sold 200,000 shares of Eli Lilly And Co stock. The stock was sold at an average price of $113.74, for a total transaction of $22,748,000.00.
  • On Monday, November 12th, Lilly Endowment Inc sold 202,540 shares of Eli Lilly And Co stock. The stock was sold at an average price of $113.48, for a total transaction of $22,984,239.20.
  • On Wednesday, October 17th, Lilly Endowment Inc sold 174,696 shares of Eli Lilly And Co stock. The stock was sold at an average price of $113.25, for a total transaction of $19,784,322.00.
  • On Monday, October 8th, Lilly Endowment Inc sold 14,632 shares of Eli Lilly And Co stock. The stock was sold at an average price of $115.91, for a total transaction of $1,695,995.12.
  • On Wednesday, October 3rd, Lilly Endowment Inc sold 78,962 shares of Eli Lilly And Co stock. The stock was sold at an average price of $109.01, for a total transaction of $8,607,647.62.
  • On Thursday, September 27th, Lilly Endowment Inc sold 92,447 shares of Eli Lilly And Co stock. The stock was sold at an average price of $107.00, for a total transaction of $9,891,829.00.
  • On Tuesday, September 25th, Lilly Endowment Inc sold 55,590 shares of Eli Lilly And Co stock. The stock was sold at an average price of $106.41, for a total transaction of $5,915,331.90.
  • On Friday, September 7th, Lilly Endowment Inc sold 180,000 shares of Eli Lilly And Co stock. The stock was sold at an average price of $106.76, for a total transaction of $19,216,800.00.

Eli Lilly And Co stock opened at $113.58 on Friday. Eli Lilly And Co has a 1-year low of $73.69 and a 1-year high of $119.84. The company has a market capitalization of $123.43 billion, a P/E ratio of 26.54, a price-to-earnings-growth ratio of 1.82 and a beta of 0.31. The company has a quick ratio of 1.53, a current ratio of 1.91 and a debt-to-equity ratio of 0.83.

Eli Lilly And Co (NYSE:LLY) last released its quarterly earnings data on Tuesday, November 6th. The company reported $1.39 earnings per share for the quarter, beating analysts’ consensus estimates of $1.35 by $0.04. Eli Lilly And Co had a net margin of 1.85% and a return on equity of 42.84%. The business had revenue of $6.06 billion during the quarter, compared to analyst estimates of $6.04 billion. During the same period in the previous year, the business earned $1.05 EPS. Eli Lilly And Co’s revenue was up 7.1% compared to the same quarter last year. Sell-side analysts forecast that Eli Lilly And Co will post 5.58 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 10th. Investors of record on Thursday, November 15th will be paid a $0.5625 dividend. The ex-dividend date of this dividend is Wednesday, November 14th. This represents a $2.25 dividend on an annualized basis and a yield of 1.98%. Eli Lilly And Co’s dividend payout ratio is 52.57%.

A number of institutional investors have recently added to or reduced their stakes in the stock. Welch Group LLC bought a new position in Eli Lilly And Co in the 3rd quarter valued at $123,000. Zions Bancorporation bought a new position in Eli Lilly And Co in the 3rd quarter valued at $128,000. Mainstay Capital Management LLC ADV boosted its holdings in Eli Lilly And Co by 98.0% in the 3rd quarter. Mainstay Capital Management LLC ADV now owns 1,218 shares of the company’s stock valued at $131,000 after purchasing an additional 603 shares during the period. Bay Colony Advisory Group Inc d b a Bay Colony Advisors bought a new position in Eli Lilly And Co in the 2nd quarter valued at $114,000. Finally, Fort L.P. bought a new position in Eli Lilly And Co in the 2nd quarter valued at $121,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Several equities research analysts have recently issued reports on LLY shares. SunTrust Banks raised their price target on shares of Eli Lilly And Co from $105.00 to $123.00 and gave the stock a “buy” rating in a research note on Monday, October 1st. Zacks Investment Research lowered shares of Eli Lilly And Co from a “buy” rating to a “hold” rating in a research note on Friday, September 28th. Wolfe Research started coverage on shares of Eli Lilly And Co in a research note on Tuesday, October 23rd. They set a “market perform” rating and a $119.00 price target for the company. Cantor Fitzgerald restated a “buy” rating and set a $128.00 price target on shares of Eli Lilly And Co in a research note on Wednesday, October 17th. Finally, JPMorgan Chase & Co. set a $123.00 price objective on shares of Eli Lilly And Co and gave the company a “buy” rating in a research note on Friday, October 5th. Nine research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Eli Lilly And Co has a consensus rating of “Buy” and a consensus target price of $111.53.

WARNING: “Insider Selling: Eli Lilly And Co (LLY) Major Shareholder Sells 15,500 Shares of Stock” was posted by Watch List News and is the property of of Watch List News. If you are reading this story on another publication, it was illegally copied and republished in violation of U.S. and international copyright and trademark laws. The original version of this story can be viewed at https://www.watchlistnews.com/insider-selling-eli-lilly-and-co-lly-major-shareholder-sells-15500-shares-of-stock/2669404.html.

About Eli Lilly And Co

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates through two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions.

See Also: What is a Market Correction?

Insider Buying and Selling by Quarter for Eli Lilly And Co (NYSE:LLY)

Receive News & Ratings for Eli Lilly And Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eli Lilly And Co and related companies with MarketBeat.com's FREE daily email newsletter.